IP Library Granted Patent US 8,361,446
Granted Patent B2
US 8,361,446 · App. 11/919,104 · Granted Jan 29, 2013

Use of benzotriazole derivatives for photostabilisation

Inventors: Stefan Müller (Weil am Rhein, DE); Jochen Giesinger (Grenzach-Wyhlen, DE); Thomas Ehlis (Freiburg, DE); Bernd Herzog (Grenzach-Wyhlen, DE); Peter König (Lörrach, DE); Gilbert Kreyer (Saint-Louis, FR); Katja Quass (Rheinfelden, DE)
Assignee: BASF SE
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,361,446
App. No.
11/919,104
Granted
Jan 29, 2013
Kind
B2
Abstract

Use of benzotriazole derivatives of formula (1), wherein R 1 is C 1 -C 30 alkyl; C 1 C 5 alkoxy; C 1 -C 5 alkoxycarbonyl; C 5 -C 7 cycloalkyl; C 6 -C 10 aryl; aralkyl; —SO 3 M; a radical of formula (1 a ) R 3 is hydrogen; C 1 C 5 alkyl; C 1 C 5 alkoxy; halogen, preferably Cl; or hydroxy; R 4 and R 5 are each independently of the other hydrogen; or d-C 5 alkyl; m is 1 or 2; n is O or 1; if m=1, R 2 is hydrogen; unsubstituted or phenyl-substituted d-C 1 -C 12 alkyl; or C 6 -C 10 aryl; if m=2, R2 is the direct bond; or —(CH 2 ) p —; and p is 1 to 3; for enhancing the photostability of cosmetic or dermatologic compositions comprising at least one further organic UV absorber.

Claims (32)

1. A method for enhancing the photostability of cosmetic or dermatologic compositions comprising adding to said compositions an effective stabilizing amount of benzotriazole derivatives of formula

wherein

R 1 is a random statistical mixture of at least three isomeric branched secondary alkyl groups each having 8 to 30 carbon atoms and having the formula

E 1 is a straight-chain C 1 -C 14 alkyl;

E 2 is a straight-chain C 4 -C 15 alkyl; wherein the total number of carbon atoms in E 1 plus E 2 is from 7 to 29; and

R 2 is C 1 -C 5 alkyl;

wherein said compositions further comprise at least one further organic UV absorbers which are a combination of at least one of cinnamic acid derivatives and at least one of dibenzoylmethane derivatives.

2. A method according to claim 1 , wherein the benzotriazole is of formula

3. A method according to claim 1 , wherein the benzotriazole derivative is used in amounts from 0.1 to 20% based on total weight of the cosmetic or dermatological sun screen formulations.

4. A method according to claim 1 wherein the cinnamic acid derivatives are selected from the group consisting of isopentyl p-methoxycinnamate, 2-ethylhexyl 4-methoxycinnamate and ethylhexyl methoxycinnamate.

5. A method according to claim 1 wherein the dibenzoylmethane derivative is selected from the group consisting of formula

6. A cosmetic or dermatological composition comprising

(a) 0.1 to 5 weight % of a dibenzoylmethane derivative, based on the total weight of the composition;

(b) 0.1 to 10 weight % of a cinnamic acid derivative, based on the total weight of the composition;

(c) a benzotriazole derivative of formula (3)

 in an amount which is sufficient to stabilize components (a) and (b),

wherein

R 1 is a random statistical mixture of at least three isomeric branched secondary alkyl groups each having 8 to 30 carbon atoms and having the formula

E 1 is a straight-chain C 1 -C 14 alkyl;

E 2 is a straight-chain C 4 -C 15 alkyl; wherein the total number of carbon atoms in E 1 plus E 2 is from 7 to 29; and

R 2 is C 1 - 0 5 alkyl;

(d) optionally further UV absorbers; and

a cosmetically acceptable carrier.

7. A composition according to claim 6 , wherein

R 1 is C 8 -C 16 alkyl.

8. A composition according to claim 6 , wherein the benzotriazole is of formula

9. A composition according to claim 6 , wherein the benzotriazole derivative is used in amounts from 0.1 to 20% based on total weight of the cosmetic or dermatological sun screen formulations.

10. A composition according to claim 6 wherein the cinnamic acid derivatives are selected from the group consisting of isopentyl p-methoxycinnamate, 2-ethylhexyl 4-methoxycinnamate and ethylhexyl methoxycinnamate.

11. A composition according to claim 6 wherein the dibenzoylmethane derivative is selected from the group consisting of formula

12. The composition according to claim 6 wherein a) is

b) is 2-ethylhexyl 4-methoxycinnamate and

c) is

Assignments (3)
CHANGE OF NAME Recorded Dec 14, 2012
From: CIBA SPECIALTY CHEMICALS CORPORATION
To: CIBA CORPORATION
Reel/Frame 029468/0768 →
ASSET TRANSFER AGREEMENT Recorded Dec 14, 2012
From: CIBA CORPORATION
To: BASF SE
Reel/Frame 029468/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2009
From: MUELLER, STEFAN; GIESINGER, JOCHEN; EHLIS, THOMAS; HERZOG, BERND; KOENIG, PETER; KREYER, GILBERT; QUASS, KATJA
To: CIBA SPECIALTY CHEMICALS CORP.
Reel/Frame 023239/0993 →
Priority Claims (1)
EP 05103494 · Apr 28, 2005 · regional
Continuity (1)
Related Publication 20100008873A1 · Jan 14, 2010